Skip to content
Bamboo Works
Search
Register / Sign in
MSCI China
|
MSCI China Small-Cap
|
Hang Seng Index
|
Hang Seng China Enterprise
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • Eng
  • 简中
  • 繁中
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • AI/Infrastructure/Resources
    • Property
  • Fast News
  • Expert Corner
  • Audio/Video
  • China ESG
  • About
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

commercialization

Founded in 2012, Akeso is a biopharmaceutical company integrating the R&D, production and commercialization of innovative new antimicrobial drugs.

FAST NEWS: Akeso raises $247 million through share placement

The Latest: Akeso Inc. (9926.HK) announced Sunday it has entered into placement agreements to issue 31.7 million shares to six investors priced at HK$61.28 per share, representing a 4.99% discount…
October 14, 2024
9926.HK
This biotech company, which focuses on the R&D of stem cell drugs, has filed for listing on the Hong Kong Stock Exchange, hoping to get a slice from the hot stock market.

Increasing losses prompt Zephyrm Bioscience to seek funds through IPO

This biotech company, which focuses on the R&D of stem cell drugs, has filed for listing on the Hong Kong Stock Exchange, hoping to get a slice from the hot…
October 10, 2024
Founded in 2009, Bilibili has consistently lost money since its 2018 listing on the Nasdaq, though its loss narrowed last year on improving efficiency.

FAST NEWS: BlackRock cuts Bilibili H-share stake below 5%

The Latest: Asset manager BlackRock disclosed it sold about 2.85 million Hong Kong-listed shares of Bilibili Inc. (9626.HK, BILI.US) on Sept. 10, reducing its stake in the video site from…
September 16, 2024
9626.HK
BILI.US
Established in 2017, Everest develops cancer and autoimmune disorder drugs and listed in Hong Kong in 2020.

FAST NEWS: Everest Medicines loss widens on drug commercialization

The Latest: Everest Medicines Ltd. (1952.HK) announced Tuesday its revenue for the first half of this year surged about 33 times to 302 million yuan ($42.3 million), while its net loss jumped 49%…
August 28, 2024
1952.HK
MicroPort Scientific issued a positive profit alert on Monday, forecasting a 17% increase in revenue for the first half of this year, showing a significant decrease in net loss.

FAST NEWS: MicroPort Scientific loss narrows on market share increase

The Latest: MicroPort Scientific Corp. (0853.HK) issued a positive profit alert on Monday, forecasting a 17% increase in revenue for the first half of this year, showing a significant decrease in net loss. Looking…
July 9, 2024
0853.HK
WuXi AppTec has recently come under fire from U.S. politicians who want to ban government-backed projects from buying its services, causing the stock to lose about half of its value this year.

FAST NEWS: BlackRock boosts stake in battered WuXi AppTec

The latest: Asset management company BlackRock Inc. purchased 618,000 Hong Kong-listed shares of WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) on March 26, raising its stake in the drug outsourcing services company from…
April 3, 2024
2359.HK
603259.SHG
Biotech company Zai Lab reported Wednesday that its loss narrowed 24.5% to $335 million last year.

FAST NEWS: Zai Lab’s loss narrows on strengthening sales

The latest: Biotech company Zai Lab Ltd. (9688.HK; ZLAB.US) reported Wednesday that its loss narrowed 24.5% to $335 million last year. Looking up: The narrower loss owed mainly to a 25% increase in revenue…
February 28, 2024
9688.HK
ZLAB.US
Load more

Recent Articles

Founded in 2012, Akeso is a biopharmaceutical company integrating the R&D, production and commercialization of innovative new antimicrobial drugs.
October 14, 2024

FAST NEWS: Akeso raises $247 million through share placement

9926.HK
October 10, 2024

Increasing losses prompt Zephyrm Bioscience to seek funds through IPO

September 16, 2024

FAST NEWS: BlackRock cuts Bilibili H-share stake below 5%

9626.HK
BILI.US
August 28, 2024

FAST NEWS: Everest Medicines loss widens on drug commercialization

1952.HK
July 9, 2024

FAST NEWS: MicroPort Scientific loss narrows on market share increase

0853.HK
April 3, 2024

FAST NEWS: BlackRock boosts stake in battered WuXi AppTec

2359.HK
603259.SHG
February 28, 2024

FAST NEWS: Zai Lab’s loss narrows on strengthening sales

9688.HK
ZLAB.US

RELATED ARTICLES

  1. GDS does infrastructure
    February 20, 2025
    BRIEF: Ubtech raises $113 million in fourth post-IPO share placement
    9880.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

China stock insights and analysis for global investors: Bamboo Works unlocks investment opportunities in Chinese companies listed in the U.S. & Hong Kong.

  • About Us
  • Fast News
  • Audio/Video
  • Expert Corner
  • China ESG
Facebook Twitter Linkedin Weixin Weibo Youtube

Categories

  • New Energy
  • IPO
  • AI/Infrastructure/Resources
  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • Property

Newsletter

Discover hidden China stock gems in our weekly newsletter
Copyright © 2021 - 2025 Bamboo Works. All rights reserved.